Astrocytic tumor
MONDO:0021636A glial tumor of the brain or spinal cord showing astrocytic differentiation. It includes the following clinicopathological entities: pilocytic astrocytoma, diffuse astrocytoma, anaplastic astrocytoma, pleomorphic xanthoastrocytoma, subependymal giant cell astrocytoma, and glioblastoma.
Also known as: astrocytic neoplasm, astrocytic tumor, astrocytoma, no ICD-O subtype, astroglioma, astrocytoma, astrocytoma of cerebrum
2123 clinical trials for this condition and its sub-types, 6 tagged with Astrocytic tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Astrocytic tumor
-
High grade astrocytic tumor 8 trials · 673 incl. sub-types
3 sub-types
- Glioblastoma 638 trials · 651 incl. sub-types Sub-types →
- Anaplastic astrocytoma 53 trials · 101 incl. sub-types Sub-types →
- Gliomatosis cerebri 1 trial
-
Astrocytoma (excluding glioblastoma) 116 trials · 165 incl. sub-types
5 sub-types
- Anaplastic astrocytoma 53 trials · 101 incl. sub-types Sub-types →
- Low-grade astrocytoma 5 trials · 41 incl. sub-types Sub-types →
- Brain astrocytoma 2 trials · 5 incl. sub-types Sub-types →
- Cauda equina intradural extramedullary astrocytoma 0 trials
- Spinal cord astrocytoma 0 trials
-
Low grade astrocytic tumor 1 trial · 41 incl. sub-types
1 sub-type
- Low-grade astrocytoma 5 trials · 41 incl. sub-types Sub-types →
-
Adult astrocytic tumor 2 trials · 25 incl. sub-types
2 sub-types
- Adult infiltrating astrocytic neoplasm 0 trials · 25 incl. sub-types Sub-types →
- Adult brainstem astrocytoma 0 trials
-
1 sub-type
-
Childhood astrocytic tumor 1 trial · 2 incl. sub-types
4 sub-types
- Childhood pilocytic astrocytoma 1 trial Sub-types →
- Childhood brainstem astrocytoma 0 trials
- Childhood cerebellar astrocytic neoplasm 0 trials
- Childhood cerebral astrocytoma 0 trials Sub-types →
-
Infant-type hemispheric glioma 1 trial
-
Gliofibroma 0 trials
Most studied deeper sub-types
-
New drug tarlatamab targets Hard-to-Treat brain tumors
Disease control Recruiting nowThis phase 2 trial tests tarlatamab, a drug that helps immune cells attack tumor cells, in 44 adults with recurrent IDH-mutant gliomas (a type of brain tumor). The study aims to see if tarlatamab can increase immune cell activity in the tumor and potentially control the disease. …
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 26, 2026 19:02 UTC
-
Brain tumor samples used to tailor drug cocktails in recurrent glioma trial
Knowledge-focused Recruiting nowThis study tests a new way to choose drug combinations for people with recurrent high-grade astrocytic glioma, a type of aggressive brain cancer. Researchers take a sample of the tumor, grow it in the lab, and test many drug combinations to find the best one for that patient. The…
Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC